185 reports of this reaction
1.6% of all COAL TAR reports
#18 most reported adverse reaction
SKIN HAEMORRHAGE is the #18 most commonly reported adverse reaction for COAL TAR, manufactured by Kobayashi Healthcare International, Inc.. There are 185 FDA adverse event reports linking COAL TAR to SKIN HAEMORRHAGE. This represents approximately 1.6% of all 11,295 adverse event reports for this drug.
Patients taking COAL TAR who experience skin haemorrhage should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SKIN HAEMORRHAGE is a less commonly reported adverse event for COAL TAR, but still significant enough to appear in the safety profile.
In addition to skin haemorrhage, the following adverse reactions have been reported for COAL TAR:
The following drugs have also been linked to skin haemorrhage in FDA adverse event reports:
SKIN HAEMORRHAGE has been reported as an adverse event in 185 FDA reports for COAL TAR. This does not prove causation, but indicates an association observed in post-market surveillance data.
SKIN HAEMORRHAGE accounts for approximately 1.6% of all adverse event reports for COAL TAR, making it a notable side effect.
If you experience skin haemorrhage while taking COAL TAR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.